Trial reportFrontiers in public health2025
Importance of providing pharmaceutical care for patients using psychotropic medicines in community pharmacy.
Trial report in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Mental health represents a major global public health challenge significantly impacting well-being, quality of life, and mortality. Psychotropic medicines are frequently associated with drug-related problems (DRPs) that may lead to decreased quality of life (QoL), falls, hospitalizations, and increased morbidity, or mortality. Non-adherence, observed in nearly half of patients with psychiatric disorders, remains a critical issue. This study evaluated the real-life impact of community pharmacists in identifying and managing DRPs among patients using psychotropic medicines and examines how sociodemographic factors influence QoL. Methods: The randomized controlled study was conducted in six community pharmacies in the Istrian County (Croatia) among adult patients using psycholeptics or psychoanaleptics. DRPs were documented using the Pharmaceutical Care Network of Europe (PCNE) DRP Classification Version 9.1. QoL was assessed once, prior the intervention, with the WHOQoL-BREF Questionnaire. In the intervention group (A), pharmacists' intervention followed a standardized protocol, in contrast to common pharmacists' practice in Croatia provided to the participants in the control group (B). Results: Ninety-seven participants completed the study. Baseline measurement of QoL showed significantly higher scores in Physical health ( Conclusion: Community pharmacists play an important role in identifying untreated conditions, adverse drug events and associated causes of DRPs related to psychotropic medicine use. Findings support integration of structured pharmaceutical care into community pharmacy practice to enhance patient safety through prevention of adverse drug events and medication safety surveillance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.